Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial

Overview of attention for article published in Stroke, July 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 43,150 followers.

A look at combined approach in acute ischemic #stroke via @American_Heart: http://t.co/KQghOWZpiP

Current Issue: Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator ... http://t.co/alclrJCRJT

Recent Issues: Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator ... http://t.co/alclrJCRJT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.